200 related articles for article (PubMed ID: 28102901)
1. Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer-blind risk stratification over 10 years.
Pezawas T; Diedrich A; Robertson D; Winker R; Richter B; Wang L; Schmidinger H
Eur J Clin Invest; 2017 Mar; 47(3):231-240. PubMed ID: 28102901
[TBL] [Abstract][Full Text] [Related]
2. Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction.
Daniłowicz-Szymanowicz L; Kaufmann D; Rozwadowska K; Kempa M; Lewicka E; Raczak G
PLoS One; 2018; 13(5):e0196812. PubMed ID: 29723261
[TBL] [Abstract][Full Text] [Related]
3. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls.
Pezawas T; Diedrich A; Winker R; Robertson D; Richter B; Wang L; Byrne DW; Schmidinger H
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1101-8. PubMed ID: 25262115
[TBL] [Abstract][Full Text] [Related]
4. Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction.
Rodríguez-Zanella H; Muraru D; Secco E; Boccalini F; Azzolina D; Aruta P; Surkova E; Genovese D; Cavalli G; Sammarco G; Ruozi N; Tenaglia RM; Calvillo-Argüelles O; Palermo C; Iliceto S; Badano LP
JACC Cardiovasc Imaging; 2019 Oct; 12(10):1917-1926. PubMed ID: 30219408
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
Dagres N; Hindricks G
Eur Heart J; 2013 Jul; 34(26):1964-71. PubMed ID: 23644180
[TBL] [Abstract][Full Text] [Related]
7. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
[TBL] [Abstract][Full Text] [Related]
8. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
[TBL] [Abstract][Full Text] [Related]
9. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
[TBL] [Abstract][Full Text] [Related]
10. Importance of Diastolic Function for the Prediction of Arrhythmic Death: A Prospective, Observer-Blinded, Long-Term Study.
Pezawas T; Burger AL; Binder T; Diedrich A
Circ Arrhythm Electrophysiol; 2020 Feb; 13(2):e007757. PubMed ID: 31944144
[TBL] [Abstract][Full Text] [Related]
11. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
[TBL] [Abstract][Full Text] [Related]
12. Application of microvolt T-wave alternans testing in scheduling implantable cardioverter-defibrillator placement for the primary prevention of sudden cardiac death in patients with left ventricular dysfunction.
Daniłowicz-Szymanowicz L; Suchecka J; Zagożdżon P; Szwoch M; Kempa M; Raczak G
Kardiol Pol; 2015; 73(6):429-36. PubMed ID: 25371309
[TBL] [Abstract][Full Text] [Related]
13. Baroreflex sensitivity but not microvolt T-wave alternans can predict major adverse cardiac events in ischemic heart failure.
Kaufmann DK; Raczak G; Szwoch M; Wabich E; Świątczak M; Daniłowicz-Szymanowicz L
Cardiol J; 2022; 29(6):1004-1012. PubMed ID: 33001423
[TBL] [Abstract][Full Text] [Related]
14. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.
La Rovere MT; Bigger JT; Marcus FI; Mortara A; Schwartz PJ
Lancet; 1998 Feb; 351(9101):478-84. PubMed ID: 9482439
[TBL] [Abstract][Full Text] [Related]
15. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
Bloomfield DM; Bigger JT; Steinman RC; Namerow PB; Parides MK; Curtis AB; Kaufman ES; Davidenko JM; Shinn TS; Fontaine JM
J Am Coll Cardiol; 2006 Jan; 47(2):456-63. PubMed ID: 16412877
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
[TBL] [Abstract][Full Text] [Related]
17. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
[TBL] [Abstract][Full Text] [Related]
18. Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction.
Chatterjee NA; Moorthy MV; Pester J; Schaecter A; Panicker GK; Narula D; Lee DC; Goldberger JJ; Kadish A; Cook NR; Albert CM;
JAMA Cardiol; 2018 Jul; 3(7):591-600. PubMed ID: 29801082
[TBL] [Abstract][Full Text] [Related]
19. Enhancing specificity without sacrificing sensitivity: potential benefits of using microvolt T-wave alternans testing to risk stratify the MADIT-II population.
Cohen RJ
Card Electrophysiol Rev; 2003 Dec; 7(4):438-42. PubMed ID: 15071271
[TBL] [Abstract][Full Text] [Related]
20. Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: implications for identifying patients at risk for sudden cardiac death.
Amit G; Rosenbaum DS; Super DM; Costantini O
Heart Rhythm; 2010 Jun; 7(6):763-8. PubMed ID: 20156592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
